Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

A month after contracting COVID-19 in January 2021, Nicholas Pastuovic was tired, had a severe cough, hot flashes and woke in ...

Non-small cell lung cancer is the most common type of lung cancer in the UK and 47,000 people are diagnosed with it every year. Standard care includes surgery, radiotherapy, chemotherapy and ...

The U.S. Preventive Services Task Force recommends a low-dose CT scan of the chest for anyone who is between ages 50 and 80 ...

For classifying the different lung cancer stages, the TNM (Tumor, Node, Metastasis ... For these patients, the treatment ...

Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage ...

An pioneering new drug causes tiny cancer cells to glow during surgery. Ascension Saint Thomas Dr. John F. Lazar said: "It's ...

Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver ...

Cardiff Oncology's promising Phase 2 trial data for Onvansertib in colorectal cancer may lead to accelerated FDA approval, ...

Researchers have taken a major step toward developing a revolutionary approach that could transform how we fight cancer.

Different types of cancer have unique molecular "fingerprints" that can be picked up using handheld scanners in just a few ...